TMOD2
Tropomodulin-2
Also known as: NTMOD, TMOD2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZR1
- Gene
- TMOD2
- Ensembl
- ENSG00000128872
- Chromosome
- 15
- Canonical length
- 351 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center
OverviewNCBI Gene
This gene encodes a neuronal-specific member of the tropomodulin family of actin-regulatory proteins. The encoded protein caps the pointed end of actin filaments preventing both elongation and depolymerization. The capping activity of this protein is dependent on its association with tropomyosin. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2008]
Canonical amino-acid sequenceUniProt
351 residues, UniProt reviewed canonical sequence.
>Q9NZR1|TMOD2
1 MALPFQKELE KYKNIDEDEL LGKLSEEELK QLENVLDDLD PESAMLPAGF RQKDQTQKAA
61 TGPFDREHLL MYLEKEALEQ KDREDFVPFT GEKKGRVFIP KEKPIETRKE EKVTLDPELE
121 EALASASDTE LYDLAAVLGV HNLLNNPKFD EETANNKGGK GPVRNVVKGE KVKPVFEEPP
181 NPTNVEISLQ QMKANDPSLQ EVNLNNIKNI PIPTLREFAK ALETNTHVKK FSLAATRSND
241 PVAIAFADML KVNKTLTSLN IESNFITGTG ILALVEALKE NDTLTEIKID NQRQQLGTAV
301 EMEIAQMLEE NSRILKFGYQ FTKQGPRTRV AAAITKNNDL VRKKRVEADR RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMOD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 63 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 63 nTPM
- amygdala: 40 nTPM
- basal ganglia: 36 nTPM
- hippocampal formation: 33 nTPM
- cerebellum: 33 nTPM
- hypothalamus: 29 nTPM
Single-cell type
- schwann cells: 270 nCPM
- bergmann glia: 171 nCPM
- brain excitatory neurons: 135 nCPM
- oligodendrocyte progenitor cells: 119 nCPM
- brain inhibitory neurons: 119 nCPM
- other brain neurons: 110 nCPM
Immune cell
- neutrophil: 13 nTPM
- non-classical monocyte: 11 nTPM
- eosinophil: 8.6 nTPM
- classical monocyte: 5.9 nTPM
- memory B-cell: 2.7 nTPM
- intermediate monocyte: 2.4 nTPM
Brain region
- cerebral cortex: 214 nTPM
- basal ganglia: 169 nTPM
- hippocampal formation: 146 nTPM
- amygdala: 142 nTPM
- white matter: 140 nTPM
- pons: 131 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.39
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- learning or memory
- muscle contraction
- myofibril assembly
- nervous system development
- neuron-neuron synaptic transmission
- pointed-end actin filament capping
- positive regulation of G protein-coupled receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMOD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMOD2 as an antibody target. Whether an autoantibody or antibody against TMOD2 could matter depends on whether native TMOD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMOD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMOD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...